Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-10-31T23:51:36.011Z Has data issue: false hasContentIssue false

P-149 - Psychometric Validation of the Spanish Version of the Gad-2 Scale for Screening Generalized Anxiety Disorder

Published online by Cambridge University Press:  15 April 2020

J. García-Campayo
Affiliation:
Department of Psychiatry, Hospital Miguel Servet, Zaragoza
E. Zamorano
Affiliation:
Primary Care Centre Sant Antoni de Vilamajor, ABS Alt Mogent, Barcelona
M.A. Ruiz
Affiliation:
Department of Methodology, School of Psychology, Universidad Autónoma de Madrid
A. Pardo
Affiliation:
Department of Methodology, School of Psychology, Universidad Autónoma de Madrid
M. Pérez-Páramo
Affiliation:
Medical Unit, Pfizer, S.L.U., Madrid, Spain
V. López-Gómez
Affiliation:
Medical Unit, Pfizer, S.L.U., Madrid, Spain
J. Rejas
Affiliation:
Health Economics and Outcomes Research Department, Pfizer, S.L.U., Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aim

To carry out the psychometric validation of the Spanish version of the 2-items self-administered GAD-2 scale for screening probable patients with Generalized Anxiety Disorder (GAD).

Methods

The content validity was assessed by inter-ratter-agreement (item-goal congruence index of Rovinelli-Hambleton). The GAD-2 was self-administered to patients with GAD according to DSM IV criteria and their respective controls, matched by age and sex, who were recruited at random in Mental Health and Primary Care centres. Criteria validity was explored using ROC curve analysis, and sensitivity, specificity, predictive positive value and negative value for different cut-off values were determined. Concurrent validity was also explored using the HAM-A, HADS, and WHO-DAS-II scales.

Results

The study sample consisted of 212 subjects (106 patients with GAD) with a mean age of 50.38 years (SD = 16.76). No items of the scale were left blank. Floor and ceiling effects were negligible. No patients with GAD had to be assisted to fill in the questionnaire. Reliability (internal consistency) was high; Cronbach′α = 0.875. A cut-off point of 3 showed adequate values of sensitivity (91.5%) and specificity (85.8%), with AUC being statistically significant [AUC = 0.934; p < 0.001] to distinguish GAD patients from controls. Concurrent validity was also high and significant with HAM-A (0.806, p < 0.001), HADS (anxiety domain, 0.825, p < 0.001), and WHO-DAS II (0.642, p > 0.001) scales.

Conclusion

The Spanish version of the GAD-2 scale was shown to have appropriate psychometric properties to promptly detect probable cases of GAD in the Spanish cultural context under conditions of routine clinical practice.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.